Vascular Genetics Inc is categorized under Electromedical Equipment in Atlanta, GA and active since 2003.
Vascular Genetics Inc was established in 2003, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Electromedical Equipment business, which does work in the B2B market, and is classified as a Electromedical Equipment, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Richard E Otto at the company’s single location by writing to 75 5th St Nw # 313, Atlanta, Georgia GA 30308 or by phoning (404) 526-6200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vascular Genetics Inc |
| Contact Person: | Richard E Otto |
| Address: | 75 5th St Nw # 313, Atlanta, Georgia 30308 |
| Phone Number: | (404) 526-6200 |
| Website Address: | viapharmaceuticals.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Electromedical Equipment |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Vascular Genetics Inc was started in 2003 to provide professional Electromedical Equipment under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Richard E Otto for inquiries that concern Vascular Genetics Inc by calling the company number (404) 526-6200, as your correspondence is most welcome. Additionally, the physical location of the single location of Vascular Genetics Inc can be found at the coordinates 33.776981,-84.389579 as well as the street address 75 5th St Nw # 313 in Atlanta, Georgia 30308.
For its online presence, you may visit Vascular Genetics Inc’s website at viapharmaceuticals.com and engage with its social media outlets through on Twitter and on Facebook.